Elekta CE marks for Monaco v5.10 treatment planning system
Simplifying and improving the treatment planning process
24 Apr, 2015, 01:30 ET
BARCELONA, Spain, April 24, 2015 /PRNewswire/ -- Elekta has CE marked the latest version (v5.10) of its popular Monaco® treatment planning system, enabling European clinics to deliver a sophisticated radiation therapy planning solution that supports major treatment techniques including advanced 3D planning, IMRT, VMAT and stereotactic planning – all in a single system.
Monaco® v5.10 provides significant planning and QA enhancements, as well improved workflow efficiency. Advancements in 3D planning as well as the addition of MRI and forward planning capabilities further reinforces Monaco as a robust and flexible treatment planning solution. Now, users can simplify their planning with advanced time saving tools, speed up workflow and ultimately create better plans with fewer contours and therefore less variability.
Furthermore, utilizing the gold standard accuracy of the Monte Carlo algorithm, Monaco now enables users to recalculate third party plans for quality assurance checks.
- Key Monaco v5.10 benefits designed to improve planning time enable clinicians to:
- Optimize plan creation with customizable templates that can be shared across institutions
- Plan multiple patients simultaneously
- Achieve better dose conformity with state-of-the art optimization tools
- Create multiple prescriptions within a single active plan
- Quickly learn and use the system through its modern, intuitive interface
Monaco v5.10 will make its first major debut at the 3rd ESTRO Forum, April 24-28 at the Centre de Convencions Internacional de Barcelona, Elekta booth #400.
"Monaco v5.10 is designed to simplify the creation of multiple, complex treatment plans from 3D to stereotactic plans," says Richard Stark, Senior Vice President of Elekta Software. "The new features will help drive faster workflow and support clinical decisions required to make an informed choice about the most appropriate treatment."
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: [email protected]
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: [email protected]
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Share this article